Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04603625
Other study ID # 723/2020/SPER/AUSLRE
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 29, 2020
Est. completion date December 31, 2025

Study information

Verified date February 2024
Source Azienda Unità Sanitaria Locale Reggio Emilia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cerebral palsy (CP) is the most common motor disability in childhood. Among these, hip luxation represents the most frequent and clinically relevant one, affecting 72% of non-ambulatory CP children. Reconstructive surgical treatment is debated in severe CP children, for whom it is crucial to identify an effective preventive approach. The aim of our study is to verify if keeping a sitting position centering femoral heads is more effective than usual postural management (sitting with the trunk aligned and hips abducted), in preventing hip luxation in quadriplegic CP children. It's a multicenter randomized controlled study (13 sites involved). A total of 102 quadriplegic CP children, aged 1-6 years-old, classified as Gross Motor Function Measure System 4 or 5, will be recruited and randomized to usual or experimental sitting, at least 5 hours a day, for 2 years. The primary outcome will be the degree of luxation, measured by means of the Migration Percentage (MP), on pelvic radiography, at 12 and 24 months. Secondary outcomes will include compliance and Health Related-Quality of Life, using validated tools, hip pain, device cost, MRI lesions, concurrent direct neuromotor treatment, use of standing devices and spasticity treatments (botulinum toxin, per os or intrathecal baclofen, selective dorsal rhizotomy). Experimental sitting is expected to reduce the MP change compared to usual care. It will be of interest to compare compliance, QoL and costs in either groups: aspects affecting the effectiveness. Furthermore to evaluate correlations between MP and spasticity treatments, MRI lesion type, and other clinical features.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 72
Est. completion date December 31, 2025
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 1 Year to 6 Years
Eligibility Inclusion Criteria: - Cerebral palsy spastic or dyskinetic - GMFCS 4 or 5 - MP<41% - Informed Consent acquired Exclusion Criteria: - muscle contracture overcoming defined passive Range Of Motion (ROM)limits - anterior hip luxation - previous reconstructive hip surgery - preventive surgery in previous 12 months - lumbar scoliosis >20° Cobb

Study Design


Related Conditions & MeSH terms


Intervention

Other:
postural management
postural management in sitting position

Locations

Country Name City State
Italy Azienda Unità Sanitaria Locale Reggio Emilia Reggio Emilia

Sponsors (10)

Lead Sponsor Collaborator
Azienda Unità Sanitaria Locale Reggio Emilia Azienda ULSS di Verona e Provincia, Azienda Unità Sanitaria Locale della Romagna, Azienda Unita' Sanitaria Locale Di Modena, Azienda Usl di Bologna, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, IRCCS Don Carlo Gnocchi di Firenze, IRCCS Eugenio Medea, Ospedale IRCCS G. Gaslini di Genova

Country where clinical trial is conducted

Italy, 

References & Publications (16)

• Lespargot A. La luxation postéro-externe de la hanche chez l'enfant IMC ou polyhandicapé. Motricité cérébrale,1991;12:37-61

Bouwhuis CB, van der Heijden-Maessen HC, Boldingh EJ, Bos CF, Lankhorst GJ. Effectiveness of preventive and corrective surgical intervention on hip disorders in severe cerebral palsy: a systematic review. Disabil Rehabil. 2015;37(2):97-105. doi: 10.3109/09638288.2014.908961. Epub 2014 Apr 14. — View Citation

Dalen Y, Saaf M, Ringertz H, Klefbeck B, Mattsson E, Haglund-Akerlind Y. Effects of standing on bone density and hip dislocation in children with severe cerebral palsy. Adv Physiother,2010;12:187-93.

Diab M, Staheli LT. Ortopedia Pediatrica, 3° ed., Verduci ed., p.65

Galeoto G, Colucci M, Guarino D, Esposito G, Cosma E, De Santis R, Grifoni G, Valente D, Tofani M. Exploring Validity, Reliability, and Factor Analysis of the Quebec User Evaluation of Satisfaction with Assistive Technology in an Italian Population: A Cross-Sectional Study. Occup Ther Health Care. 2018 Oct;32(4):380-392. doi: 10.1080/07380577.2018.1522682. Epub 2018 Dec 31. — View Citation

Gmelig Meyling C, Ketelaar M, Kuijper MA, Voorman J, Buizer AI. Effects of Postural Management on Hip Migration in Children With Cerebral Palsy: A Systematic Review. Pediatr Phys Ther. 2018 Apr;30(2):82-91. doi: 10.1097/PEP.0000000000000488. — View Citation

Hagglund G, Goldring M, Hermanson M, Rodby-Bousquet E. Pelvic obliquity and measurement of hip displacement in children with cerebral palsy. Acta Orthop. 2018 Dec;89(6):652-655. doi: 10.1080/17453674.2018.1519104. Epub 2018 Oct 17. — View Citation

Hagglund G, Lauge-Pedersen H, Wagner P. Characteristics of children with hip displacement in cerebral palsy. BMC Musculoskelet Disord. 2007 Oct 26;8:101. doi: 10.1186/1471-2474-8-101. — View Citation

Lins LAB, Watkins CJ, Shore BJ. Natural History of Spastic Hip Disease. J Pediatr Orthop. 2019 Jul;39(Issue 6, Supplement 1 Suppl 1):S33-S37. doi: 10.1097/BPO.0000000000001347. — View Citation

Martinsson C, Himmelmann K. Effect of weight-bearing in abduction and extension on hip stability in children with cerebral palsy. Pediatr Phys Ther. 2011 Summer;23(2):150-7. doi: 10.1097/PEP.0b013e318218efc3. — View Citation

Miller SD, Juricic M, Hesketh K, Mclean L, Magnuson S, Gasior S, Schaeffer E, O'donnell M, Mulpuri K. Prevention of hip displacement in children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2017 Nov;59(11):1130-1138. doi: 10.1111/dmcn.13480. Epub 2017 Jun 2. — View Citation

Narayanan UG, Fehlings D, Weir S, Knights S, Kiran S, Campbell K. Initial development and validation of the Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD). Dev Med Child Neurol. 2006 Oct;48(10):804-12. doi: 10.1017/S0012162206001745. — View Citation

Picciolini O, LE Metayer M, Consonni D, Cozzaglio M, Porro M, Gasparroni V, Panou A, Mosca F, Portinaro NM. Can we prevent hip dislocation in children with cerebral palsy? Effects of postural management. Eur J Phys Rehabil Med. 2016 Oct;52(5):682-690. Epub 2016 May 6. — View Citation

Sproccati N, Bertana S, Battisti N, Feliciangeli A, Baroncini C, Zenesini C, Cersosimo A. Italian translation and cross-cultural adaptation of the questionnaire for the assessment of quality of life in children with cerebral palsy: Caregiver priorities and Child Health Index of Life with disabilities. Minerva Med. 2021 Oct;112(5):651-653. doi: 10.23736/S0026-4806.19.06072-5. Epub 2019 Jun 25. No abstract available. — View Citation

Terjesen T. The natural history of hip development in cerebral palsy. Dev Med Child Neurol. 2012 Oct;54(10):951-7. doi: 10.1111/j.1469-8749.2012.04385.x. Epub 2012 Aug 13. — View Citation

Wynter M, Gibson N, Willoughby KL, Love S, Kentish M, Thomason P, Graham HK; National Hip Surveillance Working Group. Australian hip surveillance guidelines for children with cerebral palsy: 5-year review. Dev Med Child Neurol. 2015 Sep;57(9):808-20. doi: 10.1111/dmcn.12754. Epub 2015 Apr 3. — View Citation

* Note: There are 16 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Migration Percentage measure of hip luxation on pelvic radiography Day 0, Month 12, Months 24
Secondary Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD) Parents will fill in a questionnaire about Health Related Quality of Life referred to their child. Minimum value 0, maximum value 100, higher scores mean a better outcome. Day 0, Month 12, Month 24
Secondary Quebec User Evaluation of Satisfaction with Assistive Technology (IT-QUEST) Parents will fill in a questionnaire measuring their satisfaction about the assistive device ensuring the desired sitting position of their child. Minimum value 1, maximum value 5,higher scores mean a better outcome. Month 12, Month 24
Secondary Incidence of pain Care givers will be interviewed about presence or absence of hip pain in the previous months during personal care and activities of daily living Day 0, Month 6, Month 12, Month 18, Month 24
Secondary Assistive devices costs Costs paid by Health Institution for sitting systems used during the study Day 0, Month 6, Month 12, Month 18, Month 24
Secondary Percentage of patients attending Botulinum Toxin-A injections Botulinum Toxin-A injections in muscles around the hip during the study will be recorded Day 0, Month 6, Month 12, Month 18, Month 24
Secondary Percentage of patients attending direct physical treatment Physiotherapy, other Neuromotor Therapy during the study Day 0, Month 6, Month 12, Month 18, Month 24
Secondary Percentage of patients using standing devices in abduction It will be recorded if the patients will be using standing devices at least 5 hours/week, less than 5 h/week or never Day 0, Month 6, Month 12, Month 18, Month 24
Secondary Type of CP (Dyskinetic or spastic) Type of CP will be recorded to evaluate any association with MP change Day 0
Secondary Percentage of patients having Intrathecal Baclofen (ITB) It will be recorded if patients have ITB to evaluate any association with MP change Day 0
Secondary Percentage of patients taking Baclofen per os Baclofen oral medication during the study will be recorded Day 0, Month 6, Month 12, Month 18, Month 24
Secondary Percentage of patients who underwent Selective Dorsal Rhizotomy (SDR) It will be recorded if patients underwent SDR in the past to evaluate any association with MP change Day 0
Secondary Age Age will be recorded to evaluate any association with MP change Day 0
Secondary Sex Sex will be recorded to evaluate any association with MP change Day 0
Secondary Type of lesion at MRI Type of lesion at MRI, according to Neonatal Neuroimaging Classification System (maldevelopments | predominant white matter injury | predominant grey matter injury | miscellaneous | Normal). Data will be registered based on previously acquired MRI, considering that the exam is mandatory for the diagnosis of cerebral palsy. It will be recorded to evaluate any association with MP change Day 0